(Q46486164)

English

ERCC1 expression as a prognostic marker in N2(+) nonsmall-cell lung cancer patients treated with platinum-based neoadjuvant concurrent chemoradiotherapy

scientific article published in September 2008

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18623378

ERCC1 expression as a prognostic marker in N2(+) nonsmall-cell lung cancer patients treated with platinum-based neoadjuvant concurrent chemoradiotherapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18623378

chemoradiotherapy

0 references

author name string

In Gyu Hwang

1

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18623378

Myung Ju Ahn

2

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18623378

Byeong Bae Park

3

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18623378

Yong Chan Ahn

4

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18623378

Joungho Han

5

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18623378

Seungkoo Lee

6

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18623378

Jhingook Kim

7

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18623378

Young Mog Shim

8

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18623378

Jin Seok Ahn

9

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18623378

Keunchil Park

10

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18623378

language of work or name

0 references

publication date

1 September 2008

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18623378

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18623378

113

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18623378

6

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18623378

1379-1386

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18623378

Psoriasin (S100A7) expression and invasive breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23693

21 January 2018

Extra-cellular signal-regulated ERK-1/ERK-2 pathway activation in human salivary gland mucoepidermoid carcinoma: association to aggressive tumor behavior and tumor cell proliferation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23693

21 January 2018

Cancer statistics, 2003.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23693

7 January 2021

based on heuristic

inferred from DOI database lookup

Revisions in the International System for Staging Lung Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23693

7 January 2021

based on heuristic

inferred from DOI database lookup

Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23693

7 January 2021

based on heuristic

inferred from DOI database lookup

High dose radiation therapy and chemotherapy as induction treatment for stage III nonsmall cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23693

7 January 2021

based on heuristic

inferred from DOI database lookup

Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23693

7 January 2021

based on heuristic

inferred from DOI database lookup

Targeted therapy in combination with gemcitabine in non-small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23693

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetic testing for chemotherapy in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23693

7 January 2021

based on heuristic

inferred from DOI database lookup

Nucleotide excision repair pathways involved in Cisplatin resistance in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23693

7 January 2021

based on heuristic

inferred from DOI database lookup

Influence of genetic markers on survival in non-small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23693

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanisms of DNA excision repair

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23693

7 January 2021

based on heuristic

inferred from DOI database lookup

Reaction mechanism of human DNA repair excision nuclease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23693

7 January 2021

based on heuristic

inferred from DOI database lookup

Repair of cisplatin--DNA adducts by the mammalian excision nuclease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23693

7 January 2021

based on heuristic

inferred from DOI database lookup

Messenger RNA levels of XPAC and ERCC1 in ovarian cancer tissue correlate with response to platinum-based chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23693

7 January 2021

based on heuristic

inferred from DOI database lookup

ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23693

7 January 2021

based on heuristic

inferred from DOI database lookup

ERCC1 and thymidylate synthase mRNA levels predict survival for colorectal cancer patients receiving combination oxaliplatin and fluorouracil chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23693

7 January 2021

based on heuristic

inferred from DOI database lookup

Excision repair cross-complementation group 1 polymorphism predicts overall survival in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23693

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification of differentially expressed genes contributing to radioresistance in lung cancer cells using microarray analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23693

7 January 2021

based on heuristic

inferred from DOI database lookup

Regional lymph node classification for lung cancer staging

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23693

7 January 2021

based on heuristic

inferred from DOI database lookup

Mediastinal Lymph Node Clearance After Docetaxel-Cisplatin Neoadjuvant Chemotherapy Is Prognostic of Survival in Patients With Stage IIIA pN2 Non–Small-Cell Lung Cancer: A Multicenter Phase II Trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23693

7 January 2021

based on heuristic

inferred from DOI database lookup

DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23693

7 January 2021

based on heuristic

inferred from DOI database lookup

Is trimodality approach better then bimodality in stage IIIA, N2 positive non-small cell lung cancer?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23693

7 January 2021

based on heuristic

inferred from DOI database lookup

Potential impact on survival of improved tumor downstaging and resection rate by preoperative twice-daily radiation and concurrent chemotherapy in stage IIIA non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23693

7 January 2021

based on heuristic

inferred from DOI database lookup

ERCC1 expression is a predictor of survival in resected patients with non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23693

7 January 2021

based on heuristic

inferred from DOI database lookup

DNA-adduct levels as a predictor of outcome for NSCLC patients receiving daily cisplatin and radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23693

7 January 2021

based on heuristic

inferred from DOI database lookup

Ribonucleotide reductase messenger RNA expression and survival in gemcitabine/cisplatin-treated advanced non-small cell lung cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23693

7 January 2021

based on heuristic

inferred from DOI database lookup

ERCC1, hRad51, and BRCA1 protein expression in relation to tumour response and survival of stage III/IV NSCLC patients treated with chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23693

7 January 2021

based on heuristic

inferred from DOI database lookup

ERCC1 and RRM1 gene expressions but not EGFR are predictive of shorter survival in advanced non-small-cell lung cancer treated with cisplatin and gemcitabine

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23693

7 January 2021

based on heuristic

inferred from DOI database lookup

Customizing Cisplatin Based on Quantitative Excision Repair Cross-Complementing 1 mRNA Expression: A Phase III Trial in Non–Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23693

7 January 2021

based on heuristic

inferred from DOI database lookup

Gene expression as a predictive marker of outcome in stage IIB-IIIA-IIIB non-small cell lung cancer after induction gemcitabine-based chemotherapy followed by resectional surgery

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23693

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.23693

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18623378

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18623378

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46486164&oldid=2113466682"